Vaxart, Inc.
VXRT
$0.3181
-$0.0258-7.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 367.95% | 134.79% | 371.35% | 223.11% | 14,650.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 367.95% | 134.79% | 371.35% | 223.11% | 14,650.00% |
| Cost of Revenue | 54.06% | 0.43% | -7.09% | -3.10% | -28.12% |
| Gross Profit | 34.83% | 21.46% | 36.53% | 11.16% | 43.93% |
| SG&A Expenses | -26.05% | -11.77% | -7.52% | 9.25% | -15.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.42% | -2.58% | -7.19% | 0.02% | -25.13% |
| Operating Income | 32.00% | 18.78% | 29.48% | 5.87% | 37.14% |
| Income Before Tax | 31.35% | 19.00% | 27.01% | 2.94% | 28.04% |
| Income Tax Expenses | 1.15% | -53.85% | 10.53% | 55.17% | 987.50% |
| Earnings from Continuing Operations | 31.02% | 19.08% | 26.98% | 2.88% | 27.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.02% | 19.08% | 26.98% | 2.88% | 27.36% |
| EBIT | 32.00% | 18.78% | 29.48% | 5.87% | 37.14% |
| EBITDA | 36.47% | 22.25% | 32.77% | 6.88% | 41.71% |
| EPS Basic | 56.98% | 45.94% | 44.83% | 22.22% | 32.58% |
| Normalized Basic EPS | 57.26% | 45.94% | 44.90% | 22.31% | 40.03% |
| EPS Diluted | 56.98% | 45.94% | 44.27% | 22.22% | 32.58% |
| Normalized Diluted EPS | 57.26% | 45.94% | 44.90% | 22.31% | 40.03% |
| Average Basic Shares Outstanding | 60.44% | 49.61% | 32.31% | 24.85% | 7.78% |
| Average Diluted Shares Outstanding | 60.44% | 49.61% | 32.31% | 24.85% | 7.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |